BCAX.O - | Stock Price & Latest News | Reuters

Jan 8, 2025 · Get Bicara Therapeutics Inc (BCAX.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments

5%
OFF

Bicara Therapeutics (BCAX) Stock Price, News & Analysis

2 weeks from now

Jan 8, 2025 · Bicara Therapeutics' stock was trading at $17.42 at the beginning of 2025. Since then, BCAX shares have decreased by 12.5% and is now trading at $15.25. View the best …

marketbeat.com

$15.59
OFF

Bicara Therapeutics (Nasdaq:BCAX) - Stock Price, News & Analysis ...

2 weeks from now

Jan 5, 2025 · Summary of share price highs, lows and changes for Bicara Therapeutics; Historical stock prices; Current Share Price: US$15.59: 52 Week High: US$28.09: 52 Week Low

simplywall.st

$124.25
OFF

Beacon Roofing Jumps After QXO Makes $124.25 A Share Takeover …

2 weeks from now

8 hours ago · "QXO has proposed to acquire Beacon for $124.25 in cash per share, a compelling price for your shareholders that delivers a significant, immediate premium," QXO CEO Brad …

seekingalpha.com

FAQs about BCAX.O - | Stock Price & Latest News | Reuters Coupon?

What does bcax stand for?

Find the latest Bicara Therapeutics Inc. (BCAX) stock quote, history, news and other vital information to help you with your stock trading and investing. ...

Is bcax (bcax) a good stock to buy?

BCAX is trading within a range we consider fairly valued. Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. ...

Where is bcax based?

The company was incorporated in 2018 and is based in Boston, Massachusetts. Trailing total returns as of 12/31/2024, which may include dividends or other distributions. Benchmark is S&P 500 Select to analyze similar companies using key performance metrics; select up to 4 stocks. BCAX does not have Company Insights ...

Does FMR LLC own Bicara Therapeutics Inc (bcax)?

On September 16, 2024, FMR LLC (Trades, Portfolio) marked a significant portfolio addition by purchasing 2,495,333 shares of Bicara Therapeutics Inc (NASDAQ:BCAX), a clinical-stage biopharmaceutical company. This transaction, executed at a price of $25.41 per share, represents a new holding for the firm within its diverse investment portfolio. ...

Why did RA Capital acquire Bicara Therapeutics Inc (bcax)?

On September 16, 2024, RA Capital Management, L.P., a prominent investment firm, executed a significant transaction by acquiring 6,955,993 shares of Bicara Therapeutics Inc (NASDAQ:BCAX). This move not only reflects RA Capital's strategic investment approach but also highlights its focus on innovative biotechnology ventures. ...

Will qxo buy Beacon?

"QXO has proposed to acquire Beacon for $124.25 in cash per share, a compelling price for your shareholders that delivers a significant, immediate premium," QXO CEO Brad Jacobs wrote in a letter to Beacon's chairman. ...